205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.51%
Revenue growth under 50% of NXPI's 3.19%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
2.75%
Gross profit growth at 50-75% of NXPI's 4.10%. Martin Whitman would question if cost structure or brand is lagging.
2.63%
EBIT growth below 50% of NXPI's 8.18%. Michael Burry would suspect deeper competitive or cost structure issues.
2.40%
Operating income growth under 50% of NXPI's 8.18%. Michael Burry would be concerned about deeper cost or sales issues.
2.95%
Net income growth under 50% of NXPI's 9.14%. Michael Burry would suspect the firm is falling well behind a key competitor.
3.03%
EPS growth under 50% of NXPI's 10.62%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
3.96%
Diluted EPS growth under 50% of NXPI's 10.71%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.11%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.21%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.20%
Dividend growth at 50-75% of NXPI's 0.36%. Martin Whitman would question if the firm lags in returning cash to shareholders.
-9.04%
Negative OCF growth while NXPI is at 9.04%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
58.23%
FCF growth above 1.5x NXPI's 13.06%. David Dodd would verify if the firm’s strategic investments yield superior returns.
94.62%
10Y revenue/share CAGR under 50% of NXPI's 202.24%. Michael Burry would suspect a lasting competitive disadvantage.
55.90%
5Y revenue/share CAGR at 50-75% of NXPI's 81.36%. Martin Whitman would worry about a lagging mid-term growth trajectory.
38.84%
3Y revenue/share CAGR at 50-75% of NXPI's 63.50%. Martin Whitman would question if the firm lags behind competitor innovations.
491.32%
10Y OCF/share CAGR at 50-75% of NXPI's 731.79%. Martin Whitman might fear a structural deficiency in operational efficiency.
191.60%
5Y OCF/share CAGR above 1.5x NXPI's 75.12%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
97.03%
3Y OCF/share CAGR under 50% of NXPI's 215.72%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
928.53%
Below 50% of NXPI's 2680.28%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
138.70%
Positive 5Y CAGR while NXPI is negative. John Neff might view this as a strong mid-term relative advantage.
83.99%
Below 50% of NXPI's 3515.61%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
56.79%
Below 50% of NXPI's 425.27%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
42.46%
Positive 5Y equity/share CAGR while NXPI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
67.39%
Positive short-term equity growth while NXPI is negative. John Neff sees a strong advantage in near-term net worth buildup.
575.06%
Dividend/share CAGR of 575.06% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
129.88%
Dividend/share CAGR of 129.88% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
49.37%
Below 50% of NXPI's 122.84%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
5.53%
AR growth well above NXPI's 0.22%. Michael Burry fears inflated revenue or higher default risk in the near future.
7.85%
Inventory growth well above NXPI's 10.26%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.43%
Asset growth 1.25-1.5x NXPI's 2.19%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
5.24%
BV/share growth above 1.5x NXPI's 0.88%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-5.65%
We’re deleveraging while NXPI stands at 0.01%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
0.51%
R&D dropping or stable vs. NXPI's 2.17%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
4.46%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.